View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
March 25, 2022

Medtronic reports first implant in study of tibial neuromodulation device

The device stimulates the posterior tibial nerve to transmit electrical impulses that regulate the bladder’s neural activity.

Medtronic has announced that its investigational implantable tibial neuromodulation (TNM) device has been implanted in the first patient for its TITAN 2 pivotal study.

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

The multicentre, prospective study is designed to assess the TNM device’s safety and efficacy in people with overactive bladder (OAB).

It will include approximately 130 OAB patients, recruited from up to 30 sites across the US.

At present, the company provides percutaneous tibial neuromodulation (PTNM) therapy through its NURO system, however, the therapy needs repeated patient visits to a clinic to receive the therapy.

The minimally invasive TNM device works by stimulating the posterior tibial nerve near the ankle to transmit electrical impulses that regulate the bladder’s neural activity.

Medtronic noted that the device would deliver ongoing treatment without requiring additional clinic visits.

This helps to reduce the burden on both patients and physicians.

Medtronic pelvic health business president Mira Sahney said: “Medtronic’s decades of experience with implantable neuromodulation, existing proprietary technology platforms and the proven effectiveness of our PTNM4 therapy uniquely positions us to bring implantable TNM to the market.

“TITAN 2 demonstrates our commitment to investing in the future and expanding access to advanced therapies for the treatment of incontinence.”

The company launched the TITAN 1 feasibility study last April to characterise the procedure for the implantable TNM device in bladder incontinence patients.

It will prepare to file regulatory submission to seek approval from the US Food and Drug Administration (FDA) after completion of the TITAN 2 study.

This month, Rockley Photonics and Medtronic agreed to a partnership for the development of the next generation of wearable healthcare monitoring devices.

Related Companies

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network